EFFEKTIVNOST' I BEZOPASNOST' TAMSULOZINA DLYa ZhENShchIN S INFRAVEZIKAL'NOY OBSTRUKTsIEY


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Full Text

Restricted Access

References

  1. Урология: национальное руководство / Под ред. Н. А Лопаткина. ГЭОТАР-МЕДИА, 2009. 1024 с.
  2. Lee K.-S., Han D. H., Lee Y.-S., et al. Efficacy and Safety of Tamsulosin for the Treatment of Non-neurogenic Voiding Dysfunction in Females: A 8-Week Prospective Study. J Korean Med Sci. 2010;25(1):117—122.
  3. Скрябин Г. Н., Александров В. П., Кореньков Д. Г. и др. Циститы. СПб.; 2006. 127 с.
  4. Nitti V. W., Tu L. M., Gitlin J. Diagnosing bladder outlet obstruction in women. J. Urol. 1999;61:1535-1540.
  5. Andersson K. E. Storage and voiding symptoms: Pathophysiologic aspects. Urology 2003;62:3-10.
  6. Taylor J. A. III, Kuchel G. A. Detrusor underactivity: Clinical features and pathogenesis of an underdiagnosed geriatric condition. J. Am. Geriatr. Soc. 2006; 54:1920-1932.
  7. Boyle P., Robertson C., Mazzetta C. et al.; UrEpik Study Group. The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study. BJU Int. 2003;92(4):409-414.
  8. Pinnock C., Marshall V. R. Troublesome lower urinary tract symptoms in the community: a prevalence study. Med. J. Aust. 1997;167(2):72—75.
  9. Hajebrahimi S., Asrbadr Y. A., Azaripour A., Sadeghi-Bazargan H. Effect of tamsulosin versus prazosin on clinical and urodynamic parameters in women with voiding difficulty: a randomized clinical trial. Int. J. Gen. Med. 2011; 4: 35-39.
  10. Groutz A., Blaivas J. G. Non-neurogenic female voiding dysfunction. Curr. Opin. Urol. 2002;12:311-316.
  11. Groutz A., Gordon D., Lessing J. B. et al. Prevalence and characteristics of voiding difficulties in women: Are subjective symptoms substantiated by objective urodynamic data? Urology 1999;54:268-272.
  12. Diokno A. C., Brock B. M., Brown M. B. et al. Prevalence of urinary incontinence and other urological symptoms in the noninstitutionalized elderly. J. Urol. 1986;136:1022-1025.
  13. Akikwala T. V., Fleischman N., Nitti V. W. Comparison of diagnostic criteria for female bladder outlet obstruction. J. Urol. 2006; 176: 2093-2097.
  14. Pischedda A., Pirozzi Farina F., Madonia M. et al. Use of alpha1-blockers in female functional bladder neck obstruction. Urol. Int. 2005;74(3):256—261.
  15. Chassagne S., Bernier P. A., Haab F. et al. Proposed cutoff values to define bladder outlet obstruction in women. Urology 1998; 51:408-411.
  16. Docherty J. R. Subtypes of functional alpha1-adrenoceptor. Cell. Mol. Life Sci. 2010;67(3):405—417.
  17. Yablonsky F., Riffaud J. P., Lacolle J. Y. et al. Alpha 1- and alpha 2-adrenoceptors in the smooth muscle of male and female rabbit urethra. Eur. J. Pharmacol. 1986;121: 1-8.
  18. Morita T., Latifpour J., O'Hollaren B. et al. Sex differences in function and distribution of alpha 1- and alpha 2-adrenoceptors in rabbit urethra. Am. J. Physiol. 1987;252:F1124-F1128.
  19. Kim N. N., Min K., Huang Y. H. et al. Biochemical and functional characterization of alpha-adrenergic receptors in the rabbit vagina. Life Sci. 2002;71(24):2909—2920.
  20. Nasu K., Moriyama N., Fukasawa R. et al. Quantification and distribution of alpha1-adrenoceptor subtype mRNAs in human proximal urethra. Br. J. Pharmacol. 1998;123:1289-1293.
  21. Okutsu H., Matsumoto S., Hanai T. et al. Effects of tamsulosin on bladder blood flow and bladder function in rats with bladder outlet obstruction. Urology. 2010;75(1):235—240.
  22. Mizuno H., Yamamoto T., Okutsu H. et al. Effect of tamsulosin on bladder microcirculation in a rat ischemia-reperfusion model, evaluated by pencil lens charge-coupled device microscopy system. Urology. 2010;76(5):1266.e1—5.
  23. Mittra S., Malhotra S., Naruganahalli K. S. et al. Role of peripheral 5-HT1A receptors in detrusor over activity associated with partial bladder outlet obstruction in female rats. Eur. J. Pharmacol. 2007;561(1—3):189—193.
  24. Okutsu H., Ohtake A., Ukai M. et al. Effect of tamsulosin on spontaneous bladder contraction in conscious rats with bladder outlet obstruction: comparison with effect on intraurethral pressure. Eur. J. Pharmacol. 2006;545(2—3):185—191.
  25. Yokoyama O., Yusup A., Oyama N. et al. Improvement in bladder storage function by tamsulosin depends on suppression of C-fiber urethral afferent activity in rats. J.Urol. 2007;177(2):771—775.
  26. Bae J. H., Jung P. B., Lee J. G. The effects of alpha-adrenoceptor antagonists on the urethral perfusion pressure of the female rat. BJU Int. 2005;96(7):1131—1135.
  27. Ohtake A., Sato S., Saitoh C. et al. Effects of tamsulosin on hypogastric nerve stimulation-induced intraurethral pressure elevation in male and female dogs under anesthesia. Eur. J. Pharmacol. 2004;497(3):327-334.
  28. Ohtake A., Sato S., Sasamata M. et al. Effects of tamsulosin on resting urethral pressure and arterial blood pressure in anaesthetized female dogs. J. Pharm. Pharmacol. 2006;58(3):345-350.
  29. Reitz A., Haferkamp A., Kyburz T. et al. The effect of tamsulosin on the resting tone and the contractile behaviour of the female urethra: a functional urodynamic study in healthy women. Eur. Urol. 2004;46(2):235—240.
  30. Chang S. J., Chiang I. N., Yu H. J. The effectiveness of tamsulosin in treating women with voiding difficulty. Int. J. Urol. 2008; 15(11):981-985.
  31. Pummangura N., Kochakarn W. Efficacy of tamsulosin in the treatment of lower urinary tract symptoms (LUTS) in women. Asian. J. Surg. 2007;30:131-137.
  32. Costantini E., Lazzeri M., Bini V. et al. Open-label, longitudinal study of tamsulosin for functional bladder outlet obstruction in women. Urol. Int. 2009;83(3):311-315.
  33. Yamanishi T., Yasuda K., Kamai T. et al. Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor. Int. J. Urol. 2004; 11: 88-96.
  34. Kim S. O., Hwang E. C., Oh K. J. et al. Efficacy and safety of combined therapy with tamsulosin and tolterodine in female patients with a maximal flow rate less than 12 ml/s. Int. Urogynecol. J. 2011;22(10):1287-1291.
  35. Станкович Е. Ю., Борисов В. В., Демина Т. Л. Тамсулозин в лечении детрузорно-сфинктерной диссенергии мочевого пузыря у больных рассеянным склерозом. Урология. 2004;4:48-52.
  36. Mann R. D., Biswas P., Freemantle S. et al. The pharmacovigilance of tamsulosin: event data on 12484 patients. BJU Int. 2000; 85(4):446-450.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies